Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-02-27

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira, Inc.'s irinotecan hydrochloride under an original generic application, authorizing its use as a generic anticancer agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)